The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in adults and children.
A fast-acting treatment pill can help new moms with postpartum depression in just a couple of weeks — and it’s so new, many ...
UK MHRA approves Serum Life Sciences’ Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease: United Kingdom Saturday, November 8, 2025, 14:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback